LB Pharmaceuticals Inc (LBRX)
NASDAQ: LBRX · Real-Time Price · USD
19.50
+0.25 (1.30%)
At close: Dec 5, 2025, 4:00 PM EST
19.89
+0.39 (2.00%)
After-hours: Dec 5, 2025, 7:34 PM EST
LB Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Selling, General & Admin | 13.44 | 13.66 | 3.53 | 1.46 |
| Research & Development | 8.64 | 51.17 | 7.85 | 1.35 |
| Operating Expenses | 22.07 | 64.83 | 11.38 | 2.81 |
| Operating Income | -22.07 | -64.83 | -11.38 | -2.81 |
| Interest Expense | - | - | -4.83 | -2.15 |
| Interest & Investment Income | 1.42 | 1.72 | 0.81 | 0.07 |
| Other Non Operating Income (Expenses) | 1.37 | -0.95 | 16.22 | -9.46 |
| EBT Excluding Unusual Items | -19.28 | -64.06 | 0.83 | -14.35 |
| Gain (Loss) on Sale of Investments | 0.48 | 0.96 | 0.33 | 0 |
| Other Unusual Items | - | - | -7.44 | - |
| Pretax Income | -18.8 | -63.1 | -6.27 | -14.35 |
| Income Tax Expense | 0 | 0 | 0 | 0 |
| Net Income | -18.8 | -63.1 | -6.28 | -14.35 |
| Net Income to Common | -18.8 | -63.1 | -6.28 | -14.35 |
| Shares Outstanding (Basic) | 25 | 0 | 0 | 0 |
| Shares Outstanding (Diluted) | 25 | 0 | 0 | 0 |
| Shares Change (YoY) | 10035.57% | 0.87% | 8.02% | - |
| EPS (Basic) | -0.74 | -250.61 | -25.14 | -62.09 |
| EPS (Diluted) | -0.74 | -250.61 | -25.14 | -62.09 |
| Free Cash Flow | -23.02 | -53.82 | -12.12 | -2.73 |
| Free Cash Flow Per Share | -0.91 | -213.75 | -48.55 | -11.80 |
| EBITDA | -21.76 | -64.74 | -11.37 | -2.81 |
| D&A For EBITDA | 0.32 | 0.09 | 0 | 0 |
| EBIT | -22.07 | -64.83 | -11.38 | -2.81 |
Source: S&P Capital IQ. Standard template.
Financial Sources.